Although it is rare, bone cancer is a serious health concern that affects thousands of people annually. In 2024 alone, there ...

OS Therapies signed agreements for the commercial manufacture of OST-HER2 as it prepares for an FDA meeting and potential BLA submission. Phase 2b data show OST-HER2 significantly improved 12-month ...

Cancer specialists have long known that anemia, caused by a lack of healthy red blood cells, can arise when cancer metastasizes to the bone, but it’s been unclear why. A research team led by Princeton ...

Bone cancer in the leg, while relatively uncommon, presents with specific warning signs that warrant immediate medical attention. Understanding these symptoms enables individuals to seek prompt ...

The Cancer Prevention and Research Institute of Texas recently awarded a grant to TTUHSC’s Balakrishna Koneru, Ph.D., to help improve outcomes for osteosarcoma, a common type of bone cancer diagnosed ...

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies. A study from researchers at the ...